Cyproterone Acetate-Induced Acute Liver Failure: A Case Report and Review of the Literature.
J Clin Exp Hepatol
; 11(6): 739-741, 2021.
Article
em En
| MEDLINE
| ID: mdl-34866850
Cyproterone acetate (CPA), a hydroxyprogesterone derivative, is used to treat advanced prostate cancer and infrequently in women for acne, breast cancer and hirsutism. Transient mild elevation in levels of liver enzymes is reported in 10-30% of patients, and acute liver failure (ALF) is uncommon. Here, we discuss the first case of CPA-induced ALF from India and the available literature.
ALF, Acute liver failure; ALT, Alanine transaminase; CPA, Cyproterone acetate; DILI, Drug-induced liver injury; HAV, Hepatitis A virus; HBsAg, Hepatitis B surface antigen; HCV, Hepatitis C virus; HEV, Hepatitis E virus; MELD, Model for end-stage liver disease; RUCAM, Roussel Uclaf Causality Assessment Method; acute liver failure; cyproterone acetate; drug-induced liver injury
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Tipo de estudo:
Prognostic_studies
Idioma:
En
Ano de publicação:
2021
Tipo de documento:
Article